Skip to content

Quick ratio at other companies

Pfizer logo
PfizerPFE
1.2×0.0×
Amgen logo
AmgenAMGN
+0.1×
Incyte logo
IncyteINCY
3.5×+1.6×
Tango Therapeutics logo
Tango TherapeuticsTNGX
27.4×+21.1×
CG Oncology logo
CG OncologyCGON
31.3×+0.3×
Scholar Rock logo
Scholar RockSRRK
8.6×-1.6×

Other financials

Income statement

See full
Operating income-$103.6M-38.3%
Net income-$97.4M-35.2%
EPS (diluted)-$0.53-1.9%

Balance sheet

See full
Cash & equivalents$241.2M+91.4%
Total debt$15.5M-9.4%
Total equity$607.7M+177%
Total assets$903.0M+218%

Cash flow

See full
Operating cash flow-$86.9M-30.6%
CapEx$449.0K-17.9%
Free cash flow-$87.3M-30.2%

Valuation

See full
Market cap$5.9B+816%
Enterprise value$5.68B+951%
P/S749.8×

Profitability

See full
Operating margin-1,044.3%
Net margin-950.4%
FCF margin-184.7%

Returns & leverage

See full
Return on equity-85.7%+1.7pp
Debt / equity-0.1×
Current ratio15.1×+10.0×

Where this comes from

Calculated from Cogent Biosciences, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cogent Biosciences, Inc.'s quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cogent Biosciences, Inc.'s quick ratio?
Cogent Biosciences, Inc. (COGT) reported quick ratio of 15.1× in Q1 2026.
How has Cogent Biosciences, Inc.'s quick ratio changed year-over-year?
Cogent Biosciences, Inc.'s quick ratio increased by 195.3% year-over-year, from 5.1× to 15.1×.
What is the long-term trend for Cogent Biosciences, Inc.'s quick ratio?
Over 5 years (2020 to 2025), Cogent Biosciences, Inc.'s quick ratio has grown at a -5.3% compound annual growth rate (CAGR), from 18.7× to 14.2×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.